On June 18, 2025, Roth Capital released its updated analyst rating for PolyPid (PYPD, Financial). Analyst Boobalan Pachaiyappan has chosen to maintain the current "Buy" rating, indicating continued confidence in the company's prospects.
However, there has been a revision in the price target. The target price has been lowered from $12.00 to $9.00, reflecting a significant decrease of 25%. This adjustment suggests a more cautious outlook on the stock's potential growth.
Despite the lowered price target, the maintained "Buy" rating signals that Roth Capital still views PolyPid (PYPD, Financial) as a valuable investment opportunity. The updated price target and rating provide investors with key insights into the stock's expected performance in the market.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 4 analysts, the average target price for PolyPid Ltd (PYPD, Financial) is $12.75 with a high estimate of $15.00 and a low estimate of $9.00. The average target implies an upside of 276.53% from the current price of $3.39. More detailed estimate data can be found on the PolyPid Ltd (PYPD) Forecast page.
Based on the consensus recommendation from 4 brokerage firms, PolyPid Ltd's (PYPD, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
